Daniel SontupeMarket Access
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email